5,478 research outputs found
Billy Hodson (Robin), Dick Christensen (Martin Larson, Robin\u27s father), and Alice Corleissen (Ruth Larson, Robin\u27s mother), scene from Jack Hochhauser\u27s "No Strings on Me" performed at Kingsbury Hall, University of Utah, November 19-20, 1954
No full textNegative of a photograph of Billy Hodson (Robin), Dick Christensen (Martin Larson, Robin\u27s father), and Alice Corleissen (Ruth Larson, Robin\u27s mother), in a scene from Jack Hochhauser\u27s "No Strings on Me," performed at Kingsbury Hall, University of Utah, November 19-20, 1954
Billy Hodson (Robin), Dick Christensen (Martin Larson, Robin\u27s father), and Alice Corleissen (Ruth Larson, Robin\u27s mother), scene from Jack Hochhauser\u27s "No Strings on Me" performed at Kingsbury Hall, University of Utah, November 19-20, 1954 [02]
No full textColor slide photograph of Billy Hodson as Robin, Dick Christensen as Martin Larson (Robin\u27s father), and Alice Corleissen as Ruth Larson (Robin\u27s mother), in a scene from Jack Hochhauser\u27s "No Strings on Me," performed at Kingsbury Hall, University of Utah. November 19-20, 1954
Billy Hodson (Robin), Dick Christensen (Martin Larson, Robin\u27s father), and Alice Corleissen (Ruth Larson, Robin\u27s mother), scene from Jack Hochhauser\u27s "No Strings on Me" performed at Kingsbury Hall, University of Utah, November 19-20, 1954 [01]
No full textColor slide photograph of Billy Hodson as Robin, Dick Christensen as Martin Larson (Robin\u27s father), and Alice Corleissen as Ruth Larson (Robin\u27s mother), in a scene from Jack Hochhauser\u27s "No Strings on Me," performed at Kingsbury Hall, University of Utah. November 19-20, 1954
Happy Hour with Robin Sacks
No full textRobin Sacks is the author of Get Off My Bus!: How to Get Clarity, Get in the Driver\u27s Seat, and Get Moving in Your Life! Introduction by Kristen Kuhlman, LSW, LHNA, MBA/HCM DHA Candidate
Public management : Reinventing Government: a symposium. by Robin Butler
No full texttag=1 data=Public management : Reinventing Government: a symposium. by Robin Butler
tag=2 data=Butler, Robin
tag=3 data=Public Administration,
tag=4 data=72
tag=5 data=2
tag=6 data=Summer 1994
tag=7 data=263-270.
tag=8 data=MANAGEMENT%PUBLIC SERVICE
tag=10 data=The author indicates how the major themes of the book [Reinventing Government] can be seen to correspond with many of the recent management initiatives in UK government.
tag=11 data=1994/6/8
tag=12 data=94/0490
tag=13 data=CABThe author indicates how the major themes of the book [Reinventing Government] can be seen to correspond with many of the recent management initiatives in UK government
Robin Becker, 16th Annual ODU Literary Festival
No full textRobin Becker is the author of Giacometti’s Dog, published in 1990 by the University of Pittsburgh Press. Her previous books are Backtalk and Personal Effects, both published by Alice James Books She has received fellowships in poetry from the Massachusetts Artists Foundation and the National Endowment for the Arts. Her poems appear in many journals including Agni, The American Poetry Review, The Kenyon Review, and Ploughshares. She has published book reviews in Belles Lettres, The Boston Globe, The Boston Review, Prairie Schooner and The Women’s Review of Books She teaches in the Program in Writing and Humanistic Studies at Massachusetts Institute of Technology. This year she is Visiting Poet at Pennsylvania State University. Robin Becker serves as Poetry Editor for The Women’s Review of Books and as a member of the board of directors of Associated Writing Programs
Surrogate endpoints:A key concept in clinical epidemiology
Full text linkSurrogate endpoints are biomarkers or intermediate outcomes that are used as substitutes for clinical outcomes of interest, often to expedite research or decision-making. In contrast, patient-important (or patient-centered) outcomes are health outcomes that are of direct relevance and importance to patients themselves; clinical trials may have measured the impact of the intervention on other endpoints related to, but different from, those of primary importance to patients. This article aims to elaborate on the use and understanding of surrogate endpoints. There should be a well-understood and scientifically grounded relationship between the surrogate (replacement) and the patient-important (target) endpoint it is intended to represent. It should be biologically plausible that changes in the surrogate will consistently and predictably reflect changes in the patient-important endpoint. The surrogate endpoint should show a threshold effect, meaning that a specific change (or state) in the surrogate with an intervention (relative to the comparator) is associated with a predictable (change in the) patient-important outcome. This helps establish a meaningful cutoff or target for the treatment effect on the surrogate endpoint. While surrogate endpoints offer advantages in certain situations, it is important to remember that their use requires careful validation to ensure they reliably predict the true clinical outcome. The validity of “surrogate endpoints” should be supported by robust scientific evidence and rigorous evaluation before these can be considered and labeled as surrogate endpoints
- …
